Physician profile
Ethan Stephens
NPI 1932723020
$543.51
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $18.71 · 2023: $206 · 2024: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.00 | 2021-2024 | Vraylar |
| Amgen INC. | $73.40 | 2021-2024 | Repatha, Otezla |
| Pfizer INC. | $58.39 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.33 | 2023 | Lifevest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.35 | 2024 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $18.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.89 | 2024 | Airsupra |
| Glaxosmithkline, LLC. | $15.87 | 2023 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $15.66 | 2021 | |
| Novo Nordisk INC | $15.01 | 2024 | Wegovy |
| Ironshore Pharmaceuticals INC. | $14.86 | 2021 | |
| Lilly USA, LLC | $14.35 | 2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $13.97 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $13.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.78 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.77 | 2023 | Nexplanon |
| Mylan Specialty L.P. | $13.36 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.